Buy Zydus Lifesciences, target price Rs 530: Yes Securities

Yes Securities has buy call on Zydus Lifesciences with a target price of Rs 530.The current market price of Zydus Lifesciences is Rs 479.85. Yes Securities recommended to keep stop loss at Rs 460.

Zydus Lifesciences., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 48550.37 Crore) operating in Pharmaceuticals sector.

Zydus Lifesciences key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2022.


Financials
For the quarter ended 31-12-2022, the company has reported a Consolidated Total Income of Rs 4400.80 Crore, up 5.30 % from last quarter Total Income of Rs 4179.10 Crore and up 18.43 % from last year same quarter Total Income of Rs 3715.80 Crore. Company has reported net profit after tax of Rs 585.30 Crore in latest quarter.

The company’s top management includes Mr.Pankaj R Patel, Dr.Sharvil P Patel, Mr.Ganesh N Nayak, Mr.Bhadresh K Shah, Mr.Mukesh M Patel, Mr.Nitin R Desai, Ms.Dharmishtaben N Raval, Ms.Apurva S Diwanji. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2022, the company has a total of 101 Crore shares outstanding.

Investment Rationale
Bullish ABC breakout suggests follow through moves on P&F chart.

Promoter/FII Holdings
Promoters held 74.98 per cent stake in the company as of 31-Dec-2022, while FIIs owned 2.52 per cent, DIIs 13.61 per cent.